Veterinarians go above and (far) beyond.
Veterinarians go above and (far) beyond.
Search
We are there for our patients – even in crisis regions.
We are there for our patients – even in crisis regions.
Drug discovery Boehringer Ingelheim
Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.
Innovation in Oncology and Cancer Immunology Research
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
All hands-on deck to fight the ‘zombie’ rabies virus
We’re teaming up with communities and governments across Southeast Asia to fight rabies through vaccinations, education programs, and partnerships.
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
Uniting to stop rabies: a global and local endeavor
By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease
Solidarity with Ukraine
Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term with monetary and in kind donations.
Dog parasites: What you should know
Dog parasites: What you should know
Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
75 Years Boehringer Ingelheim in Austria
75 Years Boehringer Ingelheim in Austria
More Health: Overview
As a company that operates at the intersection of human and veterinary medicine, we have unique opportunities to advocate for disadvantaged populations.
Our FOCUS
Our FOCUS
Who we are
Embracing diversity in clinical trials: A global mandate
Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.
Digital innovation: „We change the way labs work“
QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey.
More Potential: Overview
Society continues to face challenges ranging from health to education, work prospects, living conditions, inequalities and poverty, often impacting vulnerable communities the most.
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects.
Our Commitment
Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations.
Lithuania
Lithuania
Health, Safety & Environment
Suppliers aim to ensure a safe and healthy working environment and to act in an ecological and sustainable manner.
The domino effect of cardiovascular, renal and metabolic conditions
The domino effect of cardiovascular, renal and metabolic conditions
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Our Expectations
We are committed to exemplary ethical and professional conduct both within the company and from our suppliers.
Interstitial Lung Diseases - Sound the ILD Alarm
Learn more about ILDs and why it's important to ‘sound the ILD alarm’ for early detection and treatment.